Autologous EphA2-targeting CAR-DC vaccine loaded with KRAS mutant peptide

N/A

Report date: 2022/12/02 20:01:16

Base Information

Drug NameAutologous EphA2-targeting CAR-DC vaccine loaded with KRAS mutant peptide
Drug Alias NameKRAS-EphA-2-CAR-DC
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A